Atlanta Capital Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,943,042
| Closed | -$145M | – | 170 |
|
|
2022
Q1 | $145M | Sell |
2,943,042
-15,690
| -0.5% | -$829K | 0.54% | 68 |
|
|
2021
Q4 | $165M | Sell |
2,958,732
-4,484,604
| -60% | -$247M | 0.56% | 66 |
|
|
2021
Q3 | $432M | Sell |
7,443,336
-141,775
| -2% | -$8.74M | 1.54% | 14 |
|
|
2021
Q2 | $480M | Sell |
7,585,111
-799,649
| -10% | -$52.7M | 1.66% | 9 |
|
|
2021
Q1 | $535M | Sell |
8,384,760
-113,216
| -1% | -$6.57M | 1.89% | 4 |
|
|
2020
Q4 | $445M | Buy |
8,497,976
+48,358
| +0.6% | +$2.38M | 1.6% | 12 |
|
|
2020
Q3 | $370M | Buy |
8,449,618
+93,706
| +1% | +$4.14M | 1.52% | 13 |
|
|
2020
Q2 | $368M | Buy |
8,355,912
+1,145,722
| +16% | +$48.4M | 1.56% | 13 |
|
|
2020
Q1 | $280M | Buy |
7,210,190
+425,854
| +6% | +$21.7M | 1.46% | 13 |
|
|
2019
Q4 | $384M | Buy |
6,784,336
+1,379,345
| +26% | +$76.9M | 1.59% | 16 |
|
|
2019
Q3 | $288M | Buy |
5,404,991
+731,952
| +16% | +$39.3M | 1.25% | 21 |
|
|
2019
Q2 | $273M | Buy |
4,673,039
+39,156
| +0.8% | +$2.1M | 1.22% | 24 |
|
|
2019
Q1 | $230M | Buy |
4,633,883
+15,189
| +0.3% | +$669K | 1.1% | 30 |
|
|
2018
Q4 | $172M | Sell |
4,618,694
-135,553
| -3% | -$4.93M | 0.95% | 40 |
|
|
2018
Q3 | $179M | Buy |
4,754,247
+18,007
| +0.4% | +$750K | 0.83% | 45 |
|
|
2018
Q2 | $207M | Sell |
4,736,240
-12,377
| -0.3% | -$581K | 1.04% | 38 |
|
|
2018
Q1 | $239M | Buy |
4,748,617
+3,568
| +0.1% | +$210K | 1.24% | 33 |
|
|
2017
Q4 | $312M | Sell |
4,745,049
-719,055
| -13% | -$45.7M | 1.64% | 19 |
|
|
2017
Q3 | $327M | Buy |
5,464,104
+33,162
| +0.6% | +$1.97M | 1.85% | 16 |
|
|
2017
Q2 | $352M | Sell |
5,430,942
-175,279
| -3% | -$11.1M | 2.06% | 12 |
|
|
2017
Q1 | $350M | Buy |
5,606,221
+143,945
| +3% | +$8.66M | 2.15% | 6 |
|
|
2016
Q4 | $315M | Buy |
5,462,276
+59,853
| +1% | +$3.54M | 2.01% | 9 |
|
|
2016
Q3 | $321M | Sell |
5,402,423
-244,977
| -4% | -$15.1M | 2.13% | 7 |
|
|
2016
Q2 | $350M | Buy |
5,647,400
+194,145
| +4% | +$12M | 2.34% | 4 |
|
|
2016
Q1 | $336M | Buy |
5,453,255
+6,356
| +0.1% | +$375K | 2.39% | 4 |
|
|
2015
Q4 | $331M | Buy |
5,446,899
+120,342
| +2% | +$7.16M | 2.43% | 3 |
|
|
2015
Q3 | $269M | Buy |
5,326,557
+76,540
| +1% | +$4.08M | 2.02% | 7 |
|
|
2015
Q2 | $271M | Buy |
5,250,017
+640,812
| +14% | +$33.2M | 1.84% | 7 |
|
|
2015
Q1 | $235M | Sell |
4,609,205
-8,868
| -0.2% | -$457K | 1.59% | 8 |
|
|
2014
Q4 | $246M | Sell |
4,618,073
-423,541
| -8% | -$21.6M | 1.69% | 6 |
|
|
2014
Q3 | $230M | Sell |
5,041,614
-28,267
| -0.6% | -$1.33M | 1.65% | 9 |
|
|
2014
Q2 | $240M | Buy |
5,069,881
+106,958
| +2% | +$4.98M | 1.64% | 9 |
|
|
2014
Q1 | $228M | Buy |
4,962,923
+293,006
| +6% | +$13.6M | 1.57% | 11 |
|
|
2013
Q4 | $226M | Buy |
4,669,917
+103,758
| +2% | +$4.86M | 1.48% | 12 |
|
|
2013
Q3 | $198M | Buy |
4,566,159
+18,340
| +0.4% | +$782K | 1.41% | 13 |
|
|
2013
Q2 | $186M | Buy |
+4,547,819
| New | +$190M | 1.41% | 14 |
|
Other funds holding XRAY
NI
Atlanta Capital Management's XRAY Position: Q2 2022 in Review
Atlanta Capital Management sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 2,943,042 shares — an estimated $145M sold.
Atlanta Capital Management first reported a position in XRAY in Q2 2013 and held it in 36 quarters. The position peaked at $535M in Q1 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.
- Atlanta Capital Management reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
- Atlanta Capital Management sold 2,943,042 Dentsply Sirona shares in Q2 2022, an estimated $145M.
- Atlanta Capital Management first reported a position in Dentsply Sirona in Q2 2013 and held it in 36 quarters.
- Atlanta Capital Management's Dentsply Sirona position peaked at $535M in Q1 2021.
- 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.
Based on Atlanta Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.